Some evidence has demonstrated the utility of a measurement of plasma levels of a specific byproduct of apoptosis in liver cells—caspase-generated cytokeratin 18 fragments—in the diagnosis of NASH in adults[83]. This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatohepatitis.